Corvus Pharmaceuticals
CRVS
CRVS
38 hedge funds and large institutions have $67.5M invested in Corvus Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
11.73% less ownership
Funds ownership: 73.14% → 61.4% (-12%)
Holders
38
Holding in Top 10
2
Calls
$204K
Puts
$13K
Top Buyers
| 1 | +$879K | |
| 2 | +$588K | |
| 3 | +$217K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$201K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$128K |
Top Sellers
| 1 | -$6.17M | |
| 2 | -$2.01M | |
| 3 | -$629K | |
| 4 |
BlackRock
New York
|
-$596K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$231K |